Differential roles of cyclooxygenase-2-related signaling in regulating hypothalamic neuronal activity under various acute stresses

Journal of Veterinary Medical Science

Volumn 76, Issue 2, 2014, Pages 219-227

  Ma, Yanbo ^a   Matsuwaki, Takashi ^a   Yamanouchi, Keitaro ^a   Nishihara, Masugi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

C Fos; COX 2; Hypothalamus; Stress

Indexed keywords

ANTIDIABETIC AGENT; CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PROTEIN C FOS; SULFONAMIDE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; EXERCISE; GENE EXPRESSION REGULATION; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MALE; NITROBENZENES; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; SULFONAMIDES;

EID: 84897619056     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.13-0234     Document Type: Article

References (32)

1. Abizaid, A. and Woodside, B. 2002. Food intake and neuronal activation after acute 2DG treatment are attenuated during lactation. Physiol. Behav. 75: 483-491. [Medline][CrossRef]
2. Chagra, S. L., Zavala, J. K., Hall, M. V. and Gosselink, K. L. 2011. Acute and repeated restraint differentially activate orexigenic pathways in the rat hypothalamus. Regul. Pept. 167: 70-78. [Medline][CrossRef]
3. Charmandari, E., Tsigos, C. and Chrousos, G. 2005. Endocrinology of the stress response. Annu. Rev. Physiol. 67: 259-284. [Medline][CrossRef]
4. Dallaporta, M., Pecchi, E., Jacques, C., Berenbaum, F., Jean, A., Thirion, S. and Troadec, J. D. 2007. c-Fos immunoreactivity induced by intraperitoneal LPS administration is reduced in the brain of mice lacking the microsomal prostaglandin E synthase-1 (mPGES-1). Brain Behav. Immun. 21: 1109-1121. [Medline][CrossRef]
5. Dragunow, M. and Faull, R. 1989. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods 29: 261-265. [Medline][CrossRef]
6. Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., Van De Putte, L. B. and Lipsky, P. E. 1998. Cyclooxygenase in biology and disease. FASEB J. 12: 1063-1073. [Medline]
7. Elander, L., Engström, L., Ruud, J., Mackerlova, L., Jakobsson, P. J., Engblom, D., Nilsberth, C. and Blomqvist, A. 2009. Inducible prostaglandin E2 synthesis interacts in a temporally supplementary sequence with constitutive prostaglandin-synthesizing enzymes in creating the hypothalamic-pituitary-adrenal axis response to immune challenge. J. Neurosci. 29: 1404-1413. [Medline][CrossRef]
8. Elander, L., Ruud, J., Korotkova, M., Jakobsson, P. J. and Blomqvist, A. 2010. Cyclooxygenase-1 mediates the immediate corticosterone response to peripheral immune challenge induced by lipopolysaccharide. Neurosci. Lett. 470: 10-12. [Medline][CrossRef]
9. García-Bueno, B., Serrats, J. and Sawchenko, P. E. 2009. Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli. J. Neurosci. 29: 12970-12981. [Medline][CrossRef]
10. Gavrilov, Y. V., Perekrest, S. V., Novikova, N. S. and Korneva, E. A. 2008. Stress-induced changes in cellular responses in hypothalamic structures to administration of an antigen (lipopolysaccharide) (in terms of c-Fos protein expression). Neurosci. Behav. Physiol. 38: 189-194. [Medline][CrossRef]
11. Gibbs, D. M. 1986. Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review. Psychoneuroendocrinology 11: 131-139. [Medline][CrossRef]
12. Gimpl, G. and Fahrenholz, F. 2001. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 81: 629-683. [Medline]
13. Kudo, I. and Murakami, M. 2005. Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J. Biochem. Mol. Biol. 38: 633-638. [Medline][CrossRef]
14. Lacroix, S., Valliéres, L. and Rivest, S. 1996. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type. J. Neuroimmunol. 70: 163-179. [Medline][CrossRef]
15. Ma, Y., Matsuwaki, T., Yamanouchi, K. and Nishihara, M. 2013. Cyclooxygenase-2-related signaling in the hypothalamus plays differential roles in response to various acute stresses. Brain Res. 1508: 23-33. [Medline][CrossRef]
16. Matsunaga, W., Miyata, S., Takamata, A., Bun, H., Nakashima, T. and Kiyohara, T. 2000. LPS-induced Fos expression in oxytocin and vasopressin neurons of the rat hypothalamus. Brain Res. 858: 9-18. [Medline][CrossRef]
17. Morgan, J. I. and Curran, T. 1991. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14: 421-451. [Medline][CrossRef]
18. Ogilvie, K. M., Lee, S. and Rivier, C. 1997. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei. Brain Res. 744: 83-95. [Medline][CrossRef]
19. Paxinos, G. and Watson, C. 1986. The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, San Diego.
20. Rivest, S. and Laflamme, N. 1995. Neuronal activity and neuropeptide gene transcription in the brains of immune-challenged rats. J. Neuroendocrinol. 7: 501-525. [Medline][CrossRef]
21. Rivier, C. and Vale, W. 1983. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305: 325-327. [Medline][CrossRef]
22. Salter-Venzon, D. and Watts, A. G. 2008. The role of hypothalamic ingestive behavior controllers in generating dehydration anorexia: a Fos mapping study. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295: R1009-R1019. [Medline][CrossRef]
23. Schwartz, M. W., Woods, S. C., Porte, D. Jr., Seeley, R. J. and Baskin, D. G. 2000. Central nervous system control of food intake. Nature 404: 661-671. [Medline]
24. Smith, W. L., DeWitt, D. L. and Garavito, R. M. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69: 145-182. [Medline][CrossRef]
25. Suemaru, S., Darlington, D. N., Akana, S. F., Cascio, C. S. and Dallman, M. F. 1995. Ventromedial hypothalamic lesions inhibit corticosteroid feedback regulation of basal ACTH during the trough of the circadian rhythm. Neuroendocrinology 61: 453-463. [Medline][CrossRef]
26. Tsigos, C. and Chrousos, G. P. 2002. Hypothalamic-pituitaryadrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 53: 865-871. [Medline][CrossRef]
27. Vale, W., Spiess, S., Rivier, C. and Rivier, J. 1981. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotrophin an β-endorphin. Science 213: 1394-1397. [Medline][CrossRef]
28. Windle, R. J., Shanks, N., Lightman, S. L. and Ingram, C. D. 1997. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138: 2829-2834. [Medline][CrossRef]
29. Windle, R. J., Kershaw, Y. M., Shanks, N., Wood, S. A., Lightman, S. L. and Ingram, C. D. 2004. Oxytocin attenuates stressinduced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J. Neurosci. 24: 2974-2982. [Medline][CrossRef]
30. Wolfgang, M. J. and Lane, M. D. 2006. Control of energy homeostasis: role of enzymes and intermediates of fatty acid metabolism in the central nervous system. Annu. Rev. Nutr. 26: 23-44. [Medline][CrossRef]
31. Yamaguchi, N., Ogawa, S. and Okada, S. 2010. Cyclooxygenase and nitric oxide synthase in the presympathetic neurons in the paraventricular hypothalamic nucleus are involved in restraint stress-induced sympathetic activation in rats. Neuroscience 170: 773-781. [Medline][CrossRef]
32. Zhao, D. Q. and Ai, H. B. 2011. Oxytocin and vasopressin involved in restraint water-immersion stress mediated by oxytocin receptor and vasopressin 1b receptor in rat brain. PLoS One 6: e23362. [Medline][CrossRef]